Simplex Trading
CERE

Simplex Trading’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Simplex Trading’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,700
Closed -$192K – 9901
2024
Q2 		$192K Sell
4,700
-200
-4% -$8.33K ﹤0.01% 4696
2024
Q1 		$207K Sell
4,900
-15,200
-76% -$638K ﹤0.01% 4818
2023
Q4 		$852K Sell
20,100
-29,700
-60% -$853K ﹤0.01% 3154
2023
Q3 		$1.09M Buy
49,800
+16,100
+48% +$403K ﹤0.01% 2579
2023
Q2 		$1.07M Sell
33,700
-16,100
-32% -$494K ﹤0.01% 2539
2023
Q1 		$1.21M Buy
49,800
+45,400
+1,032% +$1.33M ﹤0.01% 2409
2022
Q4 		$138K Sell
4,400
-65,000
-94% -$1.83M ﹤0.01% 4692
2022
Q3 		$1.96M Buy
69,400
+66,100
+2,003% +$1.97M ﹤0.01% 1977
2022
Q2 		$87K Buy
3,300
+3,100
+1,550% +$88K ﹤0.01% 5765
2022
Q1 		$7K Sell
200
-2,800
-93% -$81.8K ﹤0.01% 9229
2021
Q4 		$97K Sell
3,000
-36,600
-92% -$1.29M ﹤0.01% 6304
2021
Q3 		$1.06M Buy
39,600
+20,500
+107% +$576K ﹤0.01% 2969
2021
Q2 		$489K Buy
+19,100
New +$273K ﹤0.01% 4209

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Simplex Trading's CERE Position: Q3 2024 in Review

Simplex Trading sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 7,051 shares — an estimated $288K sold.

Simplex Trading first reported a position in CERE in Q2 2022 and held it in 3 quarters. The position peaked at $330K in Q2 2022. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Simplex Trading reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 7,051 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $288K.
  • Simplex Trading first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Simplex Trading's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $330K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.